# Envafolimab With Chemotherapy and Simvastatin in Advanced Biliary Tract Cancer

> **NCT07003815** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Tongji Hospital** · enrollment: 62 (estimated)

## Conditions studied

- Biliary Tract Cancer
- Advanced Cancer

## Interventions

- **DRUG:** Envafolimab + Gemcitabine + Cisplatin + Simvastatin

## Key facts

- **NCT ID:** NCT07003815
- **Lead sponsor:** Tongji Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-06
- **Primary completion:** 2026-12
- **Final completion:** 2028-06
- **Target enrollment:** 62 (ESTIMATED)
- **Last updated:** 2025-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07003815

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07003815, "Envafolimab With Chemotherapy and Simvastatin in Advanced Biliary Tract Cancer". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT07003815. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*